RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
McKesson Europe Stock

McKesson Europe P/E 2024

McKesson Europe P/E

-5.24

Ticker

CLS1.HM

ISIN

DE000CLS1001

WKN

CLS100

As of Nov 5, 2024, McKesson Europe's P/E ratio was -5.24, a -98.88% change from the -467.22 P/E ratio recorded in the previous year.

The McKesson Europe P/E history

McKesson Europe Aktienanalyse

What does McKesson Europe do?

The McKesson Europe AG is one of the largest pharmacy and pharmaceutical trading chains in Europe and has its roots in the USA. The company was founded in 1833 by John McKesson in New York City and initially focused on the sale of medical equipment and drugs for hospitals. Since then, the company has continuously evolved and expanded. In 2007, the company merged with the German Celesio AG and subsequently operated under the name McKesson Europe AG. The company now operates with over 1,500 pharmacies in more than 15 countries and employs over 39,000 people worldwide. The business model of McKesson Europe AG focuses on the distribution of medications and health and beauty products. The company's strategy is to offer a wide range of products and services to pharmacies, consumers, and clinics. The company is divided into various business segments. Prominent examples of these business segments are wholesale and pharmaceutical manufacturing, as well as involvement in online retail, consulting services for pharmacists and clinics, and the company is also an Apple OEP contractor. The wholesale division of McKesson Europe AG is one of the largest in Europe and supplies pharmacies, clinics, and specialized retailers throughout Europe. The company relies on efficient logistics to ensure fast and smooth delivery of ordered goods. Another key area in which McKesson Europe AG operates is pharmaceutical manufacturing. The company produces medications for patients and clinics. In addition, the company is also active in the online industry and operates various online shops for medications and beauty products. The company emphasizes high product quality and fast shipping. In the field of consulting and training, McKesson Europe AG supports pharmacies and clinics in optimizing their business processes and provides assistance in patient care and improving medical services. The portfolio of McKesson Europe AG is accordingly diverse and ranges from prescription and non-prescription medications to healthcare and beauty products, as well as medical devices and aids. Overall, McKesson Europe AG is a company with a long history and a wide portfolio of products and services that relies on efficient logistics and high quality and customer satisfaction. McKesson Europe ist eines der beliebtesten Unternehmen auf Eulerpool.com.

P/E Details

Deciphering McKesson Europe's P/E Ratio

The Price to Earnings (P/E) Ratio of McKesson Europe is a vital metric that investors and analysts use to determine the company’s market value relative to its earnings. It is calculated by dividing the current stock price by the earnings per share (EPS). A higher P/E ratio could suggest that investors are expecting higher future growth, while a lower ratio may indicate a potentially undervalued company or lower growth expectations.

Year-to-Year Comparison

Assessing McKesson Europe's P/E ratio on a yearly basis provides insights into the valuation trends and investor sentiment. An increasing P/E ratio over the years signifies growing investor confidence and expectations for future earnings growth, while a decreasing ratio may reflect concerns over the company's profitability or growth prospects.

Impact on Investments

The P/E ratio of McKesson Europe is a key consideration for investors aiming to balance risk and reward. A comprehensive analysis of this ratio, in conjunction with other financial indicators, aids investors in making informed decisions regarding buying, holding, or selling the company’s stocks.

Interpreting P/E Ratio Fluctuations

Fluctuations in McKesson Europe’s P/E ratio can be attributed to various factors including changes in earnings, stock price movements, and shifts in investor expectations. Understanding the underlying reasons for these fluctuations is essential for predicting future stock performance and assessing the company's intrinsic value.

Frequently Asked Questions about McKesson Europe stock

What is the price-to-earnings ratio of McKesson Europe?

The price-earnings ratio of McKesson Europe is currently -5.24.

How has the price-earnings ratio of McKesson Europe changed compared to last year?

The price-to-earnings ratio of McKesson Europe has increased by -98.88% fallen (meaning "decreased" or "dropped") compared to last year.

What consequences does a high price-earnings ratio have for investors?

A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.

What does a low price-earnings ratio mean?

A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.

Is the price-earnings ratio of McKesson Europe high compared to other companies?

Yes, the price-to-earnings ratio of McKesson Europe is high compared to other companies.

How does an increase in the price-earnings ratio of McKesson Europe affect the company?

An increase in the price-earnings ratio of McKesson Europe would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.

How does a reduction in the price-to-earnings ratio of McKesson Europe affect the company?

A decrease in the price-earnings ratio of McKesson Europe would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.

What are some factors that influence the price-earnings ratio of McKesson Europe?

Some factors that influence the price-earnings ratio of McKesson Europe are the company's growth, financial position, industry development, and the overall economic situation.

How much dividend does McKesson Europe pay?

Over the past 12 months, McKesson Europe paid a dividend of 0.83 EUR . This corresponds to a dividend yield of about 3.4 %. For the coming 12 months, McKesson Europe is expected to pay a dividend of 0.83 EUR.

What is the dividend yield of McKesson Europe?

The current dividend yield of McKesson Europe is 3.4 %.

When does McKesson Europe pay dividends?

McKesson Europe pays a quarterly dividend. This is distributed in the months of September, December, December, September.

How secure is the dividend of McKesson Europe?

McKesson Europe paid dividends every year for the past 20 years.

What is the dividend of McKesson Europe?

For the upcoming 12 months, dividends amounting to 0.83 EUR are expected. This corresponds to a dividend yield of 3.4 %.

In which sector is McKesson Europe located?

McKesson Europe is assigned to the 'Health' sector.

Wann musste ich die Aktien von McKesson Europe kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of McKesson Europe from 8/1/2022 amounting to 0.83 EUR, you needed to have the stock in your portfolio before the ex-date on 8/1/2022.

When did McKesson Europe pay the last dividend?

The last dividend was paid out on 8/1/2022.

What was the dividend of McKesson Europe in the year 2023?

In the year 2023, McKesson Europe distributed 0.83 EUR as dividends.

In which currency does McKesson Europe pay out the dividend?

The dividends of McKesson Europe are distributed in EUR.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von McKesson Europe

Our stock analysis for McKesson Europe Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of McKesson Europe Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.